Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Sep 21, 2023
Document Date
Sep 11, 2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/